MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,011 Cr | ₹1,093 Cr | ₹657 Cr | ₹804 Cr | ₹276 Cr |
What is the latest Short Term Loans and Advances ratio of MANKIND PHARMA ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹1,093 Cr |
| Mar2023 | ₹657 Cr |
| Mar2022 | ₹804 Cr |
| Mar2021 | ₹276 Cr |
How is Short Term Loans and Advances of MANKIND PHARMA Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | -7.56 | |
| Mar2024 | ₹1,093 Cr | 66.51 | |
| Mar2023 | ₹657 Cr | -18.35 | |
| Mar2022 | ₹804 Cr | 191.64 | |
| Mar2021 | ₹276 Cr | - | |
Compare Short Term Loans and Advances of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹103,361.0 Cr | 1.4% | 18% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
18% |
-1.4% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses